RESPIRERX PHAMACEUTICALS

respirerx-phamaceuticals-logo

RespireRx Pharmaceuticals Inc. is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing drugs for niche respiratory markets where premium pricing is probable. All of the Company’s current efforts are involved with sleep apnea/hypopnea, respiratory depression and respiratory distress.

#People #Website #More

RESPIRERX PHAMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
1988-01-01

Address:
Glen Rock, New Jersey, United States

Country:
United States

Website Url:
http://www.respirerx.com

Total Employee:
1+

Status:
Active

Contact:
(917) 834-7206

Email Addresses:
[email protected]

Total Funding:
12.21 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins


Current Employees Featured

not_available_image

Arnold S. Lippa
Arnold S. Lippa Chief Executive Officer @ RespireRx Phamaceuticals
Chief Executive Officer

not_available_image

Timothy Jones
Timothy Jones President, Chief Executive Officer & Board Member @ RespireRx Phamaceuticals
President, Chief Executive Officer & Board Member
2020-04-01

jeff-margolis_image

Jeff Margolis
Jeff Margolis Vice-President @ RespireRx Phamaceuticals
Vice-President

not_available_image

Robert Weingarten
Robert Weingarten CFO @ RespireRx Phamaceuticals
CFO

keith-hoffman_image

Keith Hoffman
Keith Hoffman Business development and intellectual property adviser @ RespireRx Phamaceuticals
Business development and intellectual property adviser

Stock Details


Company's stock symbol is OTCQB:RSPI

Official Site Inspections

http://www.respirerx.com

  • Host name: 82.0.153.160.host.secureserver.net
  • IP address: 160.153.0.82
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "RespireRx Phamaceuticals"

RespireRx Pharmaceuticals Inc.

Feb 13, 2024 RespireRx Organization Structure; Social Media Guidelines; NEUROTRANSMISSION; RESOLUTIONRX. Cannabinoid Platform Summary; Pharmaceutical …See details»

Company Management - RespireRx

From 2011 to 2017, Mr. Purcell was the President and founder of a Healthcare IT startup, IntelliSanté. Previously, Mr. Purcell was President of ClinPro, Inc., a mid-sized clinical research organization. At ClinPro, Mr. Purcell was responsible …See details»

RespireRx Phamaceuticals - Crunchbase Company Profile & Funding

RespireRx Pharmaceuticals Inc. is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing …See details»

RespireRx Pharmaceuticals Company Description - Stock Analysis

4 days ago RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric …See details»

RespireRx Pharmaceuticals Inc.: A Biopharmaceutical Company

RespireRx Pharmaceuticals Inc. is a leader in the discovery and development of medicines for the treatment of psychiatric and neurological disorders, with a focus on treatment options that …See details»

RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to …

Glen Rock, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and …See details»

ResolutionRx and RespireRx Pharmaceuticals Announce …

Mar 1, 2023 Collectively, ResolutionRx and RespireRx are leaders in the discovery and development of innovative and revolutionary treatments to combat diseases caused by …See details»

Company Overview - RespireRx

RespireRx is developing a pipeline of new drug products based on our broad patent portfolios across two distinct drug platforms: 1. ResolutionRx , our pharmaceutical cannabinoids platform, is developing compounds that target …See details»

RespireRx Pharmaceuticals Inc. Announces Entry into Letter of …

Glen Rock, N.J., Nov. 17, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and …See details»

RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is …

Glen Rock, N.J., May 24, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of …See details»

[ 2024] RespireRx Pharma Mckinsey 7S Analysis / Framework

Mickinsey 7S framework is used to analyze RespireRx Pharma – competitive strategy, organization structure, human resources framework, culture, mission vision, and value …See details»

Form D Form D Filing Concerning RESPIRERX PHARMACEUTICALS …

Aug 12, 2020 Research. Pricing OtherSee details»

RespireRx Organization Structure

RespireRx Organization Structure; Social Media Guidelines; NEUROTRANSMISSION; RESOLUTIONRX. Cannabinoid Platform Summary; Pharmaceutical Cannabinoids; …See details»

RESPIRERX PHARMACEUTICALS INC. Top 13F Holdings

Respirerx Pharmaceuticals is based out of Glen Rock. Cortex Pharmaceuticals' primary focus is to develop small molecule compounds that positively modulate AMPA-type glutamate …See details»

RespireRx Pharma (United States) VUCA Analysis - EMBA Pro

Managers at RespireRx Pharma needs to have a firm understanding of the Biotechnology & Drugs sector micro and macro factors to build a comprehensive strategy to tackle the volatility …See details»

RespireRx Pharmaceuticals Inc. Announces Video Interview of

Glen Rock, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), (“RespireRx” or the “Company”) a leader in the discovery and development …See details»

RespireRx Pharmaceuticals Inc.

RespireRx has recently identified and patented several new chemical series of PAM-A compounds that have the ability to enhance respiratory rhythmogenesis or ‘pacemaking’ when …See details»

RespireRx Pharmaceuticals, Inc. (RespireRx Pharmaceuticals, Inc.)

了解RespireRx Pharmaceuticals, Inc. (RespireRx Pharmaceuticals, Inc.)公司的药物管线,治疗领域,技术平台,以及它的5项临床试验, 26篇新闻和39篇文献,疾病领域:神经系统疾病,内分 …See details»

RespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum …

Jun 14, 2017 RespireRx Organization Structure; Social Media Guidelines; NEUROTRANSMISSION; RESOLUTIONRX. Cannabinoid Platform Summary; Pharmaceutical …See details»